By Andrea Rubboli, Gregory Y. H. Lip
This ebook considers paradigmatic medical situations so that it will solid gentle on key concerns in relation to non-compulsory or emergency stent implantation and using oral anticoagulation (OAC) in sufferers with atrial traumatic inflammation. the subjects addressed comprise the optimum periprocedural antithrombotic therapy (uninterrupted vs interrupted OAC, intraprocedural use of heparin and glycoprotein IIb/IIIa inhibitors, etc.), the main acceptable kind of stent (bare steel vs drug eluting vs “bioactive”), the optimum routine (e.g., triple remedy of OAC, aspirin, and clopidogrel vs the combo of OAC and a unmarried antiplatelet agent), and the main compatible length of the antithrombotic therapy prescribed at discharge (1 vs 6–12 months).
The case-based administration suggestions could be of extensive functional price within the present wellbeing and fitness care context, the place percutaneous coronary intervention is accessible even to sufferers with suitable co-morbidities, reminiscent of these warranting long term OAC, and the symptoms for OAC are a lot broader than some time past. The e-book will attraction specifically to scientific and interventional cardiologists, inner medication experts, hematologists, and kin physicians and also will be of curiosity to cardiology and inner medication citizens and fellows.
Read Online or Download Atrial Fibrillation and Percutaneous Coronary Intervention: A Case-based Guide to Oral Anticoagulation, Antiplatelet Therapy and Stenting PDF
Best critical care books
This ebook presents distinct guidance to any healthcare professional treating sufferers with emergency vascular problems. those could comprise ruptured stomach aortic aneurysms, acute limb ischemia, vascular trauma, iatrogenic vascular accidents and problems to vascular surgical procedure. The booklet presents an creation to vascular surgical operations and specializes in how one can deal with sufferers.
Peu de domaines m? dico-chirurgicaux ont connu une ? volution aussi importante que celui des neurosciences depuis 15 ans. Les auteurs de cet ouvrage sont ? los angeles fois des chercheurs et des praticiens de haut niveau. Ils ont essay? ensemble de mettre ? jour et de r? sumer les connaissances actuelles dans le domaine de l. a. neuror?
In anesthesiology, ache medication, and important care, practitioners in any respect degrees need assistance to stick present with the consistently evolving drug knowledge-base and trainees want instruments to arrange for in-training and board tests that more and more try their wisdom of pharmacology. This sensible ebook is geared toward either readerships.
Contains greater than 250 NCLEX-style questions. basic sufficient for college kids, yet complicated sufficient for RNs operating in severe care, serious care nursing demystified is a reader-friendly, targeted assessment of the necessities of this hard topic. The ebook contains studying goals, keywords, and NCLEX-style questions on the finish of every bankruptcy.
Additional resources for Atrial Fibrillation and Percutaneous Coronary Intervention: A Case-based Guide to Oral Anticoagulation, Antiplatelet Therapy and Stenting
45. 46. P. Vranckx et al. TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001–15. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, Investigators PLATO, Freij A, Thorsén M. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045–57. Sarafoff N, Martischnig A, Wealer J, Mayer K, Mehilli J, Sibbing D, Kastrati A.
CORO was performed the next morning at 10:00 by the right radial approach.
New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint. Int J Cardiol. 2015;196:133–8. 32. Pollack Jr CV, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kamphuisen PW, Kreuzer J, Levy JH, Sellke FW, Stangier J, Steiner T, Wang B, Kam CW, Weitz JI. Idarucizumab for dabigatran reversal. N Engl J Med. 2015;373:511–20. 33. Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, Mathur VS, Castillo J, Bronson MD, Leeds JM, Mar FA, Gold A, Crowther MA.
Atrial Fibrillation and Percutaneous Coronary Intervention: A Case-based Guide to Oral Anticoagulation, Antiplatelet Therapy and Stenting by Andrea Rubboli, Gregory Y. H. Lip